Regulate PD-L1's membrane orientation thermodynamics with hydrophobic nanoparticles

Xiaoqian Lin1,2,3, Xubo Lin1

  • 1Beijing Advanced Innovation Center for Biomedical Engineering, Key Laboratory of Ministry of Education for Biomechanics and Mechanobiology, School of Engineering Medicine & School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China. linxbseu@buaa.edu.cn.

Biomaterials Science
|January 3, 2025
PubMed

Insights

Hydrophobic nanoparticles alter the membrane orientation of PD-L1, enhancing T cell engagement for cancer immunotherapy. This nanomedicine approach offers a novel strategy beyond traditional PD-L1/PD-1 blocking therapies.

Area of Science:

  • Biophysics
  • Immunology
  • Nanomedicine

Background:

  • Tumor cells evade immune detection via the PD-L1/PD-1 pathway.
  • Targeting PD-L1 or PD-1 is a key strategy in cancer immunotherapy.
  • Current therapies focus on blocking the PD-L1/PD-1 binding interface.

Purpose of the Study:

  • To investigate nanoparticle-mediated regulation of PD-L1 membrane orientation.
  • To explore an alternative nanomedicine strategy for PD-L1-related immunotherapy.

Main Methods:

  • Utilized microsecond-scale coarse-grained molecular dynamics (MD) simulations.
  • Simulated ligand-modified ultra-small hydrophobic nanoparticles (NPs).
  • Analyzed the effect of NPs on PD-L1's extracellular and transmembrane domains.

Main Results:

  • Embedded hydrophobic NPs enhance the "stand up" state probability of PD-L1's extracellular domain.
  • Hydrophobic NPs promote tilting of PD-L1's transmembrane domain.
  • Ligand length and NP concentration influence these effects.

Conclusions:

  • Nanoparticle interaction with PD-L1 offers a novel immunotherapy strategy.
  • This approach modulates PD-L1 thermodynamics for improved T cell interaction.
  • Findings suggest a new nanomedicine avenue for cancer treatment.